Impact of inflammatory granulomas in rheumatic diseases
Authors:
Z. Hrnčíř
Authors place of work:
II. interní gastroenterologická klinika LF UK a FN, Hradec Králové
Published in the journal:
Čes. Revmatol., 27, 2019, No. 4, p. 178-184.
Category:
Review Article
Summary
Inflammatory granulomas represent a defense mechanism in case of damage, for example in elimination a foreign body. In pathological conditions they should be associated with a large number of infective or noninfective (immunopathological) inflammatory disorders, in rheumatic diseases, espec. with rheumatoid arthritis (RA), granulomatosis with polyangiitis (Wegener) (GPA) and eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA). Prognostic importance of inflammatory granulomas (nodules) is usually associated with noncutaneous location. For elucidation the probleme an algorithmic approach should be used: a) differential diagnostic confirmation (espec. versus malignancy) using microscopic analysis of biopsy or OP specimen in any case if possible, and b) successive approximate evaluation using a scale „multiplicity – size – location – cavitation“. Inflammatory granulomas in RA may be present elsewhere, but prognostic importance is usually associated with pulmonary, laryngeal and cardiac location. Lung malignancy mimicking pulmonary rheumatoid nodules was demonstrated in RA as twice frequent than pulmonary rheumatoid nodules. On the contrary, isolated pulmonary granuloma in GPA may be evaluated as malignancy. Inflammatory lung granuloma itself should be dangerous after cavitation with a risk of pneumothorax with acute respiratory insuficiency, or infection (bacterial abscess, mycetoma). Nonbacterial valvular damage in RA (GPA, EGPA, SLE, ect.) is usually the most important cardiac involvement, because is associated with a risk of embolism, incl. CNS, but infective endocarditis should be always excluded. Pharmacotherapy (MTX, LFM, TNFi, ect.) may accelerate not only digital, but also systemic rheumatoid nodulosis. Histopathology with detection of microscopic nodules may be useful also for confirmation the diagnosis under suspection (giant cell arteritis, ect.). In general, it is important to emphasize, that inflammatory granulomas in rheumatic diseases may represent an ambiguous probleme of clinical rheumatology, requiring urgent elucidation and subsequently an adequate therapy.
Keywords:
inflammatory granulomas – rheumatoid nodules – rheumatoid arthritis – systemic vasculitis – pulmonary granulomas – accelerated rheumatoid nodulosis
Zdroje
1. Vencovský J. Revmatoidní artritida. In: Pavelka K, Vencovský J, Šenolt L, Mann H, Štěpán J, a kol. Revmatologie. 2. vydání. Praha: Maxdorf 2018; 340–360.
2. Myasoedova E, Crowson CS, Turesson C, Gabriel SE, Matteson EL. Incidence of extra-articular rheumatoid arthritis in Olmsted County, Minnesota in 1995–2007 vs 1985–1994: a population-based study. J Rheumatol 2011; 38: 983–989.
3. Tilstra JS, Lienesch DW. Rheumatoid nodules. Dermatol Clin 2015; 33: 361–371.
4. Rak JM, Maestroni L, Balandraut N, Guis S, Boudinet H, Guizan MC, et al. Transfer of the shared epitope through microchimerism in women with rheumatoid arthritis. Arthritis Rheum 2009; 60: 73–80.
5. Chan WFN, Atkins ChJ, Naysmith D, van der Westhuizen N, Woo J. Nelson JL. Microchimerism in the rheumatoid nodules of patients with rheumatoid arthritis. Arthritis Rheum 2012; 64: 380–388.
6. Roblot V, Henry J, Meyer C, Henry Th, Chekroun M, Grimon G, et al. 18F-FDG PET/CT for extensive rheumatoid nodulosis. Eur J Nucl Med Mol Imaging 2017; 44: 2333–2334.
7. Caplan A. Certain unusual radiological appearance in the chest of coal-miners suffering from rheumatoid arthritis. Thorax 1953; 8: 29–37.
8. Hrnčíř Zb, Toušek M. Caplanův syndrom. Čas. Lék. čes. 1962; 101: 857–860.
9. Schreiber J, Koschel D, Kekow J, Waldburg N, Goette A, Merget R. Rheumatoid pneumoconiosis (Caplan’s syndrome). Eur J Intern Med 2010; 21: 168–172.
10. Koslow M, Young JR, Baquir M, Decker PA, Johnson GB, Ryu JH. Rheumatoid pulmonary nodules: clinical and imaging features compared with malignancy. Eur Radiol 2019; 29: 1684–1692.
11. Emmungil H, Yildiz F, Gözükara MY, Acikalin A. Rheumatoid pleural effusion with nodular pleuritis. A rare presentation or rheumaoid arthritis. Z Rheumatol 2015; 74: 72–74.
12. Reus-Borts MA, Hartman U. Pulmonary nodules as initial manifestation of pulmonary Sjögren’s syndrome. Ann Rheum Dis 2006; 65: 685–687.
13. Spagnolo P, Lee JS, Sverzellati N, Rossi G, Cottin V. The lung in rheumatoid arthritis. Arthritis Rheum 2018; 70: 1544–1554.
14. Lawry GV, Fireman ML, Hanafee WN, Mancuso AA, Fan PT, Bluestone R. Laryngeal involvement in rheumatoid arthritis. Arthritis Rheum 1984; 27: 873–882.
15. Sørensen WT, Møller-Andersen K, Behrendt N. Rheumatoid nodules of the larynx. J Laryngol Otology 1998; 112: 573–574.
16. Wantrease A, Trabue Ch, Atkinson J, McNabb P. Large endocardial rheumatoid nodules: a case report and review of the literature. J Comm Hosp Intern Med Perspect 2017: 7; 175–177.
17. Tennyson Ch, Kler A, Chaturvedi A, Paschalis A, Venkaterswaran R. Rheumatoid nodule of the anterior mitral valve leaflet. J Card Surg 2018; 33: 643–645.
18. Starr MS, Louwagie CR, Salomao DR. Bulbal conjunctival nodule in a patient with rheumatoid arthritis. JAMA Ophtal 2018; 136: 439–440.
19. Patatanian E, Thompson DF. A review of Methorexate–induced accelated nodulosis. Pharmacother 2002; 22: 1157–1162.
20. Ahmed SS, Arnett FC, Smith CA, Ahn Ch, Reveille JD. The HLA.DRB1*0401 allele and the development of Methotrexate–induced accelerated rheumatoid nodulosis. Medicine 2001; 80: 271–278.
21. Soukup T, Dosedel M, Nekvindova J, Kubena AA, Tacheci I, Tebbens JD, et al. The plausible association of MTHFR and ADORA2A polymorphisms with nodules in rheumatoid arthritis patients treated with methotrexate. Pharmacogen Genom 2017; 27: 43–50.
22. Yoshikawa GT, da Silva Dias GA, Fujihara S, Ferreira e Silva L, Cruz LBP, Fuzii HT, et al. Formation of multiple pulmonary nodules during treatment with leflunomide. J Bras Pneumol 2015; 41: 281–284.
23. Kellet CV, Bombardieri SG, Navarrete RA, Manriquez J. Azathioprine induced accelerated cutaneous and pulmonary nodulosis in patient with rheumatoid arthritis. Ann Bras Dermatol 2015; 90(3 Suppl 1): S162–164.
24. Talotta R, Atzeni F, Baticciotto A, Ditto MCh, Gerardi MCh. Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series. J Med Case Rep 2018; 12: 154–160.
25. Braun MG, Wagener P. Regression von peripheren und pulmonalen rheumaknoten unter rituximab-therapie. Z Rheumatol 2013: 72: 166–171.
26. Salvarini C, Ciccia F, Pipitone N. Polymyalgia rheumatica and giant cell arteritis. In: Hochberg MC, et al. (eds.) Rheumatology. 7th ed. Philadelphia: Elsevier 2019; 1384–1394.
27. Langdorf CA. Takayasu arteritis. In: Hochberg MC, et al. (eds.) Rheumatology. 7th ed. Philadelphia: Elsevier 2019; 1378–1383.
28. Zacharovský R, Vojáček J, Dominik J, Šteiner I, Hrnčíř Zb. Náhrada aortální chlopně a vzestupné aorty u pacienta s Takayasuovou arteritidou. Rozhl Chir 2009; 88: 493–496.
29. Russell B, Mohan S, Chahal R, Charette S, Pagnoux Ch. Prognostic signifikance of cavitary lung nodules in granulomatosis with polyangiitis (Wegener’s): A clinical imaging study of 255 patients. Arthritis Care Res 2018; 70: 1082–1089.
30. Holle JU, Dubrau Ch, Herlyn K, Heller M, Ambrosch P, Noelle B, et al. Rituximab for refraktory granulomatosis with polyangiitis (Wegener’s granulomatosis): comparison of efficasy in granulomatous versus vasculitic manifestations. Ann Rheum Dis 2012; 71: 327–333.
31. Gorospe L, Ajuria-Illarramendi O, de la Puente-Bujidos C, Muňoz-Molina GM, Cabaňero-Sánchez A, Moreno-Mata N, Benito-Berlinches A. PET/CT finding of granulomatosis with polyangiitis presenting as a solitary pulmonary nodule and mimicking lung cancer. J Clin Rheumatol 2019; Jan 18. doi: 10.1097/RHU.0000000000000994 [Epub ahead of print].
32. Comarmond C, Pagnoux Ch, Khellaf M, Cordier JF, Hamidou M, Viallard JF, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Arthritis Rheum 2013; 65: 270–281.
33. Šteiner I, Dušek J, Tomšová M, Hrnčíř Zb, Novotný J, Nožička Z. Syndrom Churg-Straussové. Lék. zprávy (Hradec Králové) 2002; 47: 113–125.
34. Pagnoux Ch, Seror R, Henegar C, Mahr A, Cohen P, Le Guern V, et al. Clinical feature and outcomes in 348 patients with polyarteritis nodosa. Arthritis Rheum 2010; 62: 616–626.
35. Hajj-Ali RA, Duna GR, Calabrese LH. Vasculitis of the central nervous systém. In: Ball GV, Fessler BJ, Bridges SL. (ed.). Oxford Textbook of Vasculitis. 3rd ed. Oxford: Oxford Univ Press 2014; 497–506.
Štítky
Dermatology & STDs Paediatric rheumatology RheumatologyČlánok vyšiel v časopise
Czech Rheumatology
2019 Číslo 4
Najčítanejšie v tomto čísle
- Paraneoplastic syndrom
- Recommendations of the Czech Society for Rheumatology for the treatment of gout
- Impact of inflammatory granulomas in rheumatic diseases
- The importance of achieving remission in patients with rheumatoid arthritis